HYBRID EVENT: Join us in person in Rome, Italy or attend virtually from anywhere.

11th Edition of World Congress on Infectious Diseases

June 28-30, 2027 | Rome, Italy

June 28 -30, 2027 | Rome, Italy
Infection 2027

Cell adaptation, attenuation, and vaccine efficacy of a genotype VII virulent Newcastle disease virus isolated in Taiwan

Speaker at Infectious Diseases Conference - Shu Ju Yeh
National Pingtung University of Science and Technology, Taiwan
Title : Cell adaptation, attenuation, and vaccine efficacy of a genotype VII virulent Newcastle disease virus isolated in Taiwan

Abstract:

Newcastle disease virus (NDV) is a highly contagious avian pathogen that causes severe respiratory, neurological, and gastrointestinal disorders in chickens, often resulting in high mortality. Currently, genotype VII is the predominant circulating genotype worldwide, particularly in Asia, and has recently spread to Europe. However, the cross-protective efficacy of commercially available vaccines against genotype VII remains suboptimal. In this study, virulent genotype VII field isolates from Taiwan were serially passaged to adapt to BHK21 cell and attenuation. Cytopathic effects (CPE) were continuously monitored during passaging, and viral clones were selected and purified using plaque assays. The final viral titer reached up to 10? TCID??/mL. Pathogenicity was evaluated using the mean death time (MDT) and intracerebral pathogenicity index (ICPI), specifically, MDT values ranged from 99 to 132 hours, and ICPI values were less than 0.8, both of which met the criteria for lentogenic strains. Protective efficacy was further assessed using PD?? assays and cross-protection experiments. Regardless of whether the Sato strain or genotype VII strains were used as challenge viruses, chickens immunized with different doses of the inactivated genotype VII vaccine antigen exhibited complete protection. In cross-protection studies, chickens vaccinated with either the genotype VII vaccine alone or in combination with the traditional Sato strain showed full protection against virulent challenge, whereas the Sato-only vaccinated group exhibited a mortality rate of 14.3%. Overall, these results demonstrate that genotype VII-derived NDV vaccine candidates exhibit strong immunogenicity, high potency, and effective cross-protection, supporting their potential application in NDV vaccine development.

Biography:

Shu Ju Yeh is currently a PhD student in the International Degree Program in Animal Vaccine Technology at National Pingtung University of Science and Technology, Taiwan. Her research interests include virology and immunology, with a particular focus on Newcastle disease virus, vaccine development, and avian immune responses.

Watsapp